MECLIZINE HCL and DEATH

Overview

DEATH is the #10 most commonly reported adverse reaction for MECLIZINE HCL, manufactured by Rising Pharma Holdings, Inc.. There are 105 FDA adverse event reports linking MECLIZINE HCL to DEATH. This represents approximately 2.2% of all 4,811 adverse event reports for this drug.

Patients taking MECLIZINE HCL who experience death should discuss this symptom with their healthcare provider to determine whether it may be related to their medication and what alternatives may be available.

Reporting Frequency

DEATH is a less commonly reported adverse event for MECLIZINE HCL, but still significant enough to appear in the safety profile.

Other Side Effects of MECLIZINE HCL

In addition to death, the following adverse reactions have been reported for MECLIZINE HCL:

• FATIGUE — 196 reports
• DIZZINESS — 191 reports
• DRUG INEFFECTIVE — 166 reports
• FALL — 163 reports
• NAUSEA — 160 reports
• DIARRHOEA — 131 reports
• HEADACHE — 127 reports
• PAIN — 113 reports
• ASTHENIA — 105 reports
• GAIT DISTURBANCE — 82 reports

Other Drugs Associated with DEATH

The following drugs have also been linked to death in FDA adverse event reports:

Does MECLIZINE HCL cause DEATH?

DEATH has been reported as an adverse event in 105 FDA reports for MECLIZINE HCL. This does not prove causation, but indicates an association observed in post-market surveillance data.

How common is DEATH with MECLIZINE HCL?

DEATH accounts for approximately 2.2% of all adverse event reports for MECLIZINE HCL, making it a notable side effect.

What should I do if I experience DEATH while taking MECLIZINE HCL?

If you experience death while taking MECLIZINE HCL, contact your healthcare provider. They can evaluate whether the symptom is related to your medication and discuss potential adjustments to your treatment plan. Do not stop taking prescribed medication without consulting your doctor.

Related Pages